NEW YORK (GenomeWeb) – The US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has awarded up to $21.9 million to Diassess as part of a cost-share contract to advance development of flu diagnostic technology for use in physician offices and eventually consumers' homes, the company said today.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.